Document is current
Any future updates will be listed below
-
Authors
Fritz, Ashley V. http://orcid.org/0000-0003-4664-2896
Mickus, Gregory J.
Vega, Michael A.
Renew, J. Ross
Brull, Sorin J.
- License Information
-
More Information
Article History
Received: 30 August 2019
Accepted: 17 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: Mayo Clinic Institutional Review Board Waiver #14–007053 obtained for quality improvement project.Written informed consent not required per IRB; all participants provided verbal consent to participate in the survey.
: Not applicable.
: Not applicable, the authors declare they have no competing interests. SJB has intellectual property assigned to Mayo Clinic (Rochester, MN); has received research funding from Merck & Co., Inc. (funds to Mayo Clinic) and is a consultant for Merck & Co., Inc. (Kenilworth, NJ); is a principal and shareholder in Senzime AB (publ) (Uppsala, Sweden); and a member of the Scientific Advisory Boards for ClearLine MD (Woburn, MA), The Doctors Company (Napa, CA), and NMD Pharma (Aarhus, Denmark).
